Core Viewpoint - 博拓生物 (688767.SH) reported a decline in institutional investor holdings in its third-quarter report for 2025, with a total of 57.787 million shares held by seven institutions, representing 38.70% of the company's total equity, a decrease of 5.35 percentage points from the previous quarter [1] Institutional Holdings - As of October 29, 2025, seven institutional investors disclosed holdings in 博拓生物, totaling 57.787 million shares, which accounts for 38.70% of the total share capital [1] - The institutions include 杭州拓康投资有限公司, 杭州康宇企业管理咨询合伙企业 (有限合伙), and others, with a combined institutional holding percentage down by 5.35 percentage points compared to the last quarter [1] Public Fund Disclosures - In this quarter, three new public funds were disclosed, including 中欧悦享生活混合A, 中欧行业景气一年持有混合A, and 中欧行业鑫选混合A [1] - A total of 49 public funds were not disclosed in this quarter compared to the previous quarter, including notable funds such as 广发价值核心混合A and 华夏行业景气混合A [1]
机构风向标 | 博拓生物(688767)2025年三季度已披露前十大机构持股比例合计下跌5.35个百分点